ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

NIH Updates Policy On Large Grants

May 10, 1996

Virus Program Scientific Activities Report Concluded

August 22, 1975

Army of Women, caBIG To Collaborate.

August 7, 2009

Beckman Coulter Offers Immunoassay System.

July 27, 2001

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997